Miwa Fujihara

1PUBLICATIONS
4CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 10, 2021
YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development.

Miwa Fujihara, Tadahiko Shien, Kazuhiko Shien

Pageof 1

Frequent Collaborators

1 joint publications

Tadahiko Shien

1 joint publications

Kazuhiko Shien

1 joint publications

Ken Suzawa

1 joint publications

Yidan Zhu